Dr. Arepally is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Duke University Medical Ctr
Box 3486
Durham, NC 27710Phone+1 919-620-4467
Education & Training
- University of Pennsylvania Health SystemFellowship, Hematology and Medical Oncology, 1993 - 1997
- Emory University School of MedicineResidency, Internal Medicine, 1989 - 1992
- Vanderbilt University School of MedicineClass of 1989
Certifications & Licensure
- NC State Medical License 2001 - 2025
- NM State Medical License 1997 - 2007
- GA State Medical License 1990 - 2005
- PA State Medical License 1993 - 2002
- American Board of Internal Medicine Hematology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Publications & Presentations
PubMed
- 1 citationsRed cell exchange modulates neutrophil degranulation responses in sickle cell disease.Grace M Lee, Kimberly Boyle, Milena Batchvarova, Martha Delahunty, Mark A Suggs
Transfusion. 2024-09-01 - Platelet and red cell responses to three North American pit vipers.Samuel Francis, Sanjay Khandelwal, Richard Straight, Luke Welton, Pengfei Liang
Toxicon. 2024-08-28 - Coagulation and platelet biology at the intersection of health and disease: illustrated capsules of the 11th Symposium on Hemostasis at the University of North Carolina.Maria Aleman, Gowthami M Arepally, Trevor Baglin, Lorena Buitrago, Pavel Davizon-Castillo
Research and Practice in Thrombosis and Haemostasis. 2024-03-01
Journal Articles
- Polyreactive IgM Initiates Complement Activation by PF4/heparin Complexes Through the Classical PathwayGrace M Lee, Michael Frank, Mortimer Poncz, Jennifer B Gilner, Douglas B Cines, Gowthami M Arepally, Blood
Press Mentions
- FDA, CDC Call for Pause in Use of Johnson & Johnson Vaccine After ‘Extremely Rare’ Cases of Blood ClotsApril 13th, 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: